Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Código QR

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Ryoko Nakagawa,1 Takashi Ohnishi,1 Hisanori Kobayashi,1 Toshio Yamaoka,2 Tsutomu Yajima,3 Ai Tanimura,4 Toshiya Kato,4 Kazutake Yoshizawa1 1Evidence Generation Department, Medical Affairs Division, 2Clinical Data Management Department, R&D Division, 3Biostatistics Department, Quantitative S...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Alzheimer’s disease cholinesterase inhibitor cognitive function disease progression real-world evidence Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2a217dedb86f42edbf9cf8338e2e763a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai MC, et al.
Publicado: (2015)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
por: Wattmo C, et al.
Publicado: (2013)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
por: TSUJITA,MIKI, et al.
Publicado: (2007)

Journal of Alzheimer's disease
Publicado: (1998)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
por: Tosin A. Olasehinde, et al.
Publicado: (2019)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
por: Hager K, et al.
Publicado: (2014)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
por: Kose Ozlece H, et al.
Publicado: (2018)

International journal of Alzheimer's disease

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
por: Zhou L, et al.
Publicado: (2016)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li XH, et al.
Publicado: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
por: Cai Y, et al.
Publicado: (2015)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
por: Zhang Z, et al.
Publicado: (2012)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
por: An SS, et al.
Publicado: (2016)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
por: Fowler NR, et al.
Publicado: (2018)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams CD
Publicado: (2020)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
por: Jelcic N, et al.
Publicado: (2014)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study
por: Fujimoto H, et al.
Publicado: (2017)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli MR, et al.
Publicado: (2016)

Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)

Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
por: Hyung-Jun Yoon, et al.
Publicado: (2021)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery W, et al.
Publicado: (2018)

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
por: Yin Q, et al.
Publicado: (2020)